The sole presence of either KRAB or DNMTs fused with SOX2 (both full-length and without C-terminal domain) was not effective in blocking SNB19 glioma cells in vitro (Fig. 1, A and B); thus, we decided to combine them together. The gene discussed is SOX2; the disease is central nervous system cancer.